# Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis

> **NCT00804193** · NA · COMPLETED · sponsor: **Padagis LLC** · enrollment: 553 (actual)

## Conditions studied

- Tinea Pedis

## Interventions

- **DRUG:** Ciclopirox Olamine Topical Suspension
- **DRUG:** Ciclopirox Topical Suspension 0.77%-Reference Product
- **DRUG:** Ciclopirox Olamine Topical Suspension-Placebo

## Key facts

- **NCT ID:** NCT00804193
- **Lead sponsor:** Padagis LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2004-12
- **Final completion:** 2005-04
- **Target enrollment:** 553 (ACTUAL)
- **Last updated:** 2021-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804193, "Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00804193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*